Petros Pharmaceuticals In... (PTPI)

0.10

0.00 (2.25%)

At close: Mar 03, 2025, 3:59 PM

0.10

-0.81%

After-hours: Mar 03, 2025, 07:54 PM EST

Petros Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-8.16M	-20.04M	-8.99M	-20.59M	-32.51M	-32.47M
Depreciation & Amortization	3.42M	5.6M	6.88M	6.66M	5.29M	8.06M
Stock-Based Compensation	417.23K	1.2M	1.31M	n/a	n/a	n/a
Other Working Capital	752.72K	-231.14K	-3.67M	-5.8M	7.58M	3.85M
Other Non-Cash Items	-4.08M	3.75M	186.82K	2.02M	11.9M	42.55M
Deferred Income Tax	n/a	n/a	-9.48M	-1.43M	-645.87K	-6.94K
Change in Working Capital	789.05K	-3.3M	-1.76M	-5.6M	13.09M	4.93M
Operating Cash Flow	-7.63M	-12.8M	-11.86M	-15.31M	2.53M	8.02M
Capital Expenditures	-1	n/a	n/a	-4.63K	-71.54K	-1.88M
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-4.63M	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	-4.63K	-71.54K	-1.88M
Debt Repayment	-1.46M	-1.62M	-7.19M	8.78M	-3.11M	-2.55M
Common Stock Repurchased	-2M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	13M	n/a	4.01M	21.52M	-2.9M	n/a
Financial Cash Flow	11.54M	-1.62M	18.57M	30.3M	-3.11M	-2.55M
Net Cash Flow	3.91M	-14.42M	6.71M	14.99M	-648.31K	3.6M
Free Cash Flow	-7.63M	-12.8M	-11.86M	-15.31M	2.46M	6.15M